SEC-sourced researchBeta
LEXX
Lexaria Bioscience Corp.
Company comparison ↗
Data passport
- CIK
- 0001348362
- Exchange
- Nasdaq
- Business activity
- — · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Oct 2, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| August 2024 | 464,278.0000 | Nov 28, 2025 |
| August 2025 | 705,923.0000 | Nov 28, 2025 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| August 2025 | 705,923.0000 | -11,901,841.0000 | -10,450,387.0000 | 4,175,121.0000 | 1,572,366.0000 | Nov 28, 2025 |
| August 2024 | 464,278.0000 | -5,795,345.0000 | -4,959,003.0000 | 8,867,789.0000 | 1,208,738.0000 | Nov 28, 2025 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $705.92K | August 2025 | Nov 28, 2025 | 10-K |
| Previous period revenueRevenues | $464.28K | August 2024 | Nov 28, 2025 | 10-K |
| Net incomeNetIncomeLoss | -$11.9M | August 2025 | Nov 28, 2025 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$10.45M | August 2025 | Nov 28, 2025 | 10-K |
| Total assetsAssets | $4.18M | August 2025 | Nov 28, 2025 | 10-K |
| Total liabilitiesLiabilities | $1.57M | August 2025 | Nov 28, 2025 | 10-K |